Update: 01.07.2024
Last week: 25 week 2024 (17.06.2024 - 23.06.2024)
Last full month: May 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 065 | 3.2% | 12.3% | 0.3 | 14 434 126 | 1.8% | 9.5% | 0.1 | 0.6% |
| MoM | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| YTD | 179 832 | 19.5% | 11.1% | 2.4 | 397 072 988 | 44.6% | 9.4% | 2.1 | -6.4% |
| MAT | 370 174 | 28.4% | 10.2% | 1.9 | 779 285 960 | 48.0% | 8.7% | 1.5 | 4.9% |
| BRAINMAX | |||||||||
| WoW | 1 157 | 7.7% | 100.0% | 0 | 4 269 196 | 7.1% | 100.0% | 0 | 7.7% |
| MoM | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| YTD | 25 909 | 40.8% | 100.0% | 0 | 94 088 885 | 52.2% | 100.0% | 0 | 40.8% |
| MAT | 54 161 | 89.5% | 100.0% | 0 | 193 251 547 | 104.3% | 100.0% | 0 | 89.5% |
| GOLDLINE PLUS | |||||||||
| WoW | 17 228 | -6.6% | 44.9% | -1 | 53 344 710 | -6.5% | 37.0% | -0.9 | -4.5% |
| MoM | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| YTD | 432 315 | -2.7% | 44.7% | 1.2 | 1 365 275 443 | 1.0% | 36.4% | -2.7 | -5.4% |
| MAT | 857 035 | 9.1% | 45.6% | 1.3 | 2 705 401 366 | 16.3% | 38.2% | -1.1 | 5.9% |
| MIGRENIUM | |||||||||
| WoW | 10 256 | -5.1% | 0.5% | 0 | 3 402 657 | -5.3% | 0.7% | 0 | -3.0% |
| MoM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| YTD | 300 740 | -1.3% | 0.6% | -0.1 | 91 115 828 | 65.4% | 0.7% | 0.2 | 12.9% |
| MAT | 637 561 | 2.4% | 0.5% | -0.1 | 158 700 761 | 40.3% | 0.6% | 0 | 16.6% |
| MODELAX-N | |||||||||
| WoW | 31 319 | 0.7% | 26.5% | 0.1 | 13 898 598 | 0.7% | 17.6% | 0.1 | 0.3% |
| MoM | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| YTD | 765 437 | 43.7% | 23.6% | 5 | 323 759 840 | 93.7% | 15.1% | 4.6 | 13.4% |
| MAT | 1 400 815 | 77.0% | 21.0% | 6.6 | 539 440 046 | 111.9% | 12.7% | 4.4 | 21.7% |
| REDUXIN | |||||||||
| WoW | 12 324 | -2.8% | 32.1% | 0.5 | 63 983 474 | -3.4% | 44.4% | 0.4 | -4.5% |
| MoM | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| YTD | 319 311 | -8.9% | 33.0% | -1.3 | 1 723 882 305 | 17.0% | 46.0% | 3.4 | -5.4% |
| MAT | 606 656 | -1.1% | 32.3% | -2.3 | 3 124 171 893 | 22.6% | 44.2% | 1.1 | 5.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 589 | 0.1% | 9.3% | 0.4 | 15 281 919 | 0.3% | 10.6% | 0.5 | -4.5% |
| MoM | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| YTD | 84 338 | 3.0% | 8.7% | 0.7 | 366 789 689 | 18.7% | 9.8% | 0.8 | -5.4% |
| MAT | 168 465 | 20.7% | 9.0% | 1.1 | 711 203 731 | 34.0% | 10.1% | 1.1 | 5.9% |
| SALVISAR | |||||||||
| WoW | 8 864 | 2.4% | 1.3% | 0 | 3 836 655 | 1.4% | 1.2% | 0 | -1.3% |
| MoM | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
| YTD | 263 316 | 2.2% | 1.4% | 0 | 105 123 245 | 26.4% | 1.2% | 0.1 | 1.5% |
| MAT | 504 176 | -12.6% | 1.2% | -0.3 | 185 695 059 | -4.6% | 1.1% | -0.3 | 6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 179 832 | 19.5% | 11.1% | 2.4 | 397 072 988 | 44.6% | 9.4% | 2.1 | -6.4% |
| BRAINMAX | 25 909 | 40.8% | 100.0% | 0 | 94 088 885 | 52.2% | 100.0% | 0 | 40.8% |
| GOLDLINE PLUS | 432 315 | -2.7% | 44.7% | 1.2 | 1 365 275 443 | 1.0% | 36.4% | -2.7 | -5.4% |
| MIGRENIUM | 300 740 | -1.3% | 0.6% | -0.1 | 91 115 828 | 65.4% | 0.7% | 0.2 | 12.9% |
| MODELAX-N | 765 437 | 43.7% | 23.6% | 5 | 323 759 840 | 93.7% | 15.1% | 4.6 | 13.4% |
| REDUXIN CAPS | 319 311 | -8.9% | 33.0% | -1.3 | 1 723 882 305 | 17.0% | 46.0% | 3.4 | -5.4% |
| REDUXIN FORTE | 84 338 | 3.0% | 8.7% | 0.7 | 366 789 689 | 18.7% | 9.8% | 0.8 | -5.4% |
| SALVISAR | 263 316 | 2.2% | 1.4% | 0 | 105 123 245 | 26.4% | 1.2% | 0.1 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 370 174 | 28.4% | 10.2% | 1.9 | 779 285 960 | 48.0% | 8.7% | 1.5 | 4.9% |
| BRAINMAX | 54 161 | 89.5% | 100.0% | 0 | 193 251 547 | 104.3% | 100.0% | 0 | 89.5% |
| GOLDLINE PLUS | 857 035 | 9.1% | 45.6% | 1.3 | 2 705 401 366 | 16.3% | 38.2% | -1.1 | 5.9% |
| MIGRENIUM | 637 561 | 2.4% | 0.5% | -0.1 | 158 700 761 | 40.3% | 0.6% | 0 | 16.6% |
| MODELAX-N | 1 400 815 | 77.0% | 21.0% | 6.6 | 539 440 046 | 111.9% | 12.7% | 4.4 | 21.7% |
| REDUXIN CAPS | 606 656 | -1.1% | 32.3% | -2.3 | 3 124 171 893 | 22.6% | 44.2% | 1.1 | 5.9% |
| REDUXIN FORTE | 168 465 | 20.7% | 9.0% | 1.1 | 711 203 731 | 34.0% | 10.1% | 1.1 | 5.9% |
| SALVISAR | 504 176 | -12.6% | 1.2% | -0.3 | 185 695 059 | -4.6% | 1.1% | -0.3 | 6.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 065 | 3.2% | 12.3% | 0.3 | 14 434 126 | 1.8% | 9.5% | 0.1 | 0.6% |
| BRAINMAX | 1 157 | 7.7% | 100.0% | 0 | 4 269 196 | 7.1% | 100.0% | 0 | 7.7% |
| GOLDLINE PLUS | 17 228 | -6.6% | 44.9% | -1 | 53 344 710 | -6.5% | 37.0% | -0.9 | -4.5% |
| MIGRENIUM | 10 256 | -5.1% | 0.5% | 0 | 3 402 657 | -5.3% | 0.7% | 0 | -3.0% |
| MODELAX-N | 31 319 | 0.7% | 26.5% | 0.1 | 13 898 598 | 0.7% | 17.6% | 0.1 | 0.3% |
| REDUXIN CAPS | 12 324 | -2.8% | 32.1% | 0.5 | 63 983 474 | -3.4% | 44.4% | 0.4 | -4.5% |
| REDUXIN FORTE | 3 589 | 0.1% | 9.3% | 0.4 | 15 281 919 | 0.3% | 10.6% | 0.5 | -4.5% |
| SALVISAR | 8 864 | 2.4% | 1.3% | 0 | 3 836 655 | 1.4% | 1.2% | 0 | -1.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| BRAINMAX | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| GOLDLINE PLUS | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| MIGRENIUM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| MODELAX-N | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| REDUXIN CAPS | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| REDUXIN FORTE | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| SALVISAR | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"## [1] "BRAINMAX"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs